Chien-Liang Glenn Lin
Overview
Explore the profile of Chien-Liang Glenn Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Z, Foster J, Lashley R, Wang X, Muhleman A, Masters C, et al.
PLoS One
. 2024 Nov;
19(11):e0309716.
PMID: 39531446
Extracellular vesicles (EVs) play a crucial role in intercellular communication. Characterizing EV protein composition is essential to understand EV function(s). Isolating EVs from cell culture medium is a common approach...
2.
Xu Z, Foster J, Lashley R, Wang X, Benson E, Kidd G, et al.
Front Cell Neurosci
. 2023 Sep;
17:1229731.
PMID: 37671169
Introduction: We previously discovered a pyridazine derivative compound series that can improve cognitive functions in mouse models of Alzheimer's disease. One of the advanced compounds from this series, LDN/OSU-0215111-M3, was...
3.
Wang X, Ali N, Lin C
Life Sci
. 2021 May;
280:119609.
PMID: 33991547
Gulf War illness (GWI) is a chronic and multi-symptomatic disorder affecting veterans who served in the Gulf War. The commonly reported symptoms in GWI veterans include mood problems, cognitive impairment,...
4.
Wang X, Xu Z, Zhao F, Lin K, Foster J, Xiao T, et al.
Neurobiol Stress
. 2020 Dec;
13:100240.
PMID: 33344696
Gulf War illness is associated with a combination of exposure to war-related chemical agents and traumatic stress. Currently, there are no effective treatments, and the pathophysiology remains elusive. Neurological problems...
5.
Foster J, Lashley R, Zhao F, Wang X, Kung N, Askwith C, et al.
Alzheimers Res Ther
. 2019 Aug;
11(1):75.
PMID: 31439023
Background: The lack of effective treatment options for Alzheimer's disease (AD) is of momentous societal concern. Synaptic loss is the hallmark of AD that correlates best with impaired memory and...
6.
Foster J, Zhao F, Wang X, Xu Z, Lin K, Askwith C, et al.
Neuroscience
. 2018 Jul;
388:224-238.
PMID: 30056115
Excitatory amino acid transporter 2 (EAAT2) is primarily located in perisynaptic astrocytic processes (PAP) where it plays a critical role in synaptic glutamate homeostasis. Dysregulation of EAAT2 at the translational...
7.
Takahashi K, Foster J, Lin C
Cell Mol Life Sci
. 2015 Jun;
72(18):3489-506.
PMID: 26033496
Glutamate is the predominant excitatory neurotransmitter in the central nervous system. Excitatory amino acid transporter 2 (EAAT2) is primarily responsible for clearance of extracellular glutamate to prevent neuronal excitotoxicity and...
8.
Takahashi K, Kong Q, Lin Y, Stouffer N, Schulte D, Lai L, et al.
J Exp Med
. 2015 Feb;
212(3):319-32.
PMID: 25711212
Glutamatergic systems play a critical role in cognitive functions and are known to be defective in Alzheimer's disease (AD) patients. Previous literature has indicated that glial glutamate transporter EAAT2 plays...
9.
Kong Q, Chang L, Takahashi K, Liu Q, Schulte D, Lai L, et al.
J Clin Invest
. 2014 Feb;
124(3):1255-67.
PMID: 24569372
Glial glutamate transporter EAAT2 plays a major role in glutamate clearance in synaptic clefts. Several lines of evidence indicate that strategies designed to increase EAAT2 expression have potential for preventing...
10.
Lin C, Kong Q, Cuny G, Glicksman M
Future Med Chem
. 2012 Aug;
4(13):1689-700.
PMID: 22924507
Glutamate is the primary excitatory amino acid neurotransmitter in the CNS. The concentration of glutamate in the synaptic cleft is tightly controlled by interplay between glutamate release and glutamate clearance....